Related Experiment Video
Updated: Apr 27, 2026

10:27
Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
23.9K
Pathophysiology of celiac disease.
Journal of Pediatric Gastroenterology and Nutrition
|July 1, 2014
Summary
Celiac disease (CD) is linked to specific HLA genes. While the genetic link is clear, the "multiple hit model" explains why only some individuals develop CD, considering various factors beyond genetics.
Area of Science:
- Immunology
- Genetics
- Gastroenterology
Background:
- Celiac disease (CD) is strongly associated with HLA-DQ2 and HLA-DQ8 molecules.
- These molecules present gluten-derived peptides to CD4 T cells, a key feature in CD pathogenesis.
- Tissue transglutaminase modification enhances gluten peptide binding to HLA-DQ2/8, explaining the genetic association.
Purpose of the Study:
- To explore the reasons behind the incomplete penetrance of celiac disease in genetically predisposed individuals.
- To discuss the variable age of onset and symptom presentation in celiac disease.
- To examine the role of multiple factors in celiac disease development using the multiple hit model.
Main Methods:
- Review of existing literature on celiac disease genetics and immunology.
- Discussion of the molecular mechanisms of gluten peptide presentation by HLA-DQ2/8.
- Application of the multiple hit model to explain disease variability.
Main Results:
- The genetic predisposition to celiac disease via HLA-DQ2/8 is well-established.
- The precise reasons for disease development in only a subset of HLA-DQ2/8 positive individuals remain unclear.
- Multiple extrinsic and intrinsic factors likely contribute to or protect against celiac disease development.
Conclusions:
- The strong association between celiac disease and HLA-DQ2/8 is understood at a molecular level.
- The variability in disease onset and presentation suggests a multifactorial etiology.
- The multiple hit model provides a framework for understanding the complex interplay of factors in celiac disease development.
Related Concept Videos
Gastritis-II: Pathophysiology
1.9K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.9K
Type I Diabetes II: Pathophysiology
59
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
59
Gastritis II: Pathophysiology
43
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
43
Inflammatory Bowel Disease III: Crohn's Disease
29
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
29
Inflammatory Bowel Disease II: Ulcerative Colitis
27
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal...
27
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
1.6K
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.6K

